Evidence map›Paper›PMID 41589301›Full record

ArticleFrontiers in genetics2025

Rethinking Parkinson's disease genetics in the precision medicine era: why genomic diversity matters?

Camilla Teixeira Pinheiro Gusmão, Giselli Scaini, Everton Ferreira de Souza, Rafael Antônio Vicente Lacerda, Matheus de Almeida Costa, Raja Mehanna, João Quevedo, Howard Lopes Ribeiro Junior

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Camilla Teixeira Pinheiro GusmãoCenter for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Giselli ScainiCenter for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Everton Ferreira de SouzaClinics Hospital, Faculty of Medicine, University of São Paulo, SãoPaulo, Brazil.
Rafael Antônio Vicente LacerdaJosué Monteiro de Abreu Primary Healthcare Unit, Ministry of Health of Brazil, Maranguape, Ceará, Brazil.
Matheus de Almeida CostaDepartment of Gastroenterology, Faculty of Medicine, University of São Paulo (USP), São Paulo, Brazil.
Raja MehannaUTMOve, Department of Neurology, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
João QuevedoCenter for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Howard Lopes Ribeiro JuniorCenter for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

admixture populationsgeneticgenomic diversityParkinson’s diseaseprecision medicine

Identifiers

PMID41589301
PMCPMC12832110

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.